Literature DB >> 33581845

Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers.

Maryam Hashemipour1, Homa Boroumand1, Samaneh Mollazadeh2, Vida Tajiknia3, Zahra Nourollahzadeh4, Mina Rohani Borj5, Hossein Pourghadamyari6, Neda Rahimian7, Michael R Hamblin8, Hamed Mirzaei9.   

Abstract

Gynecologic cancer is a group of any malignancies affecting reproductive tissues and organs of women, including ovaries, uterine, cervix, vagina, vulva, and endometrium. Several types of molecular mechanisms are associated with the progression of gynecologic cancers. Among it can be referred to the most widely studied non-coding RNAs (ncRNAs), specifically microRNAs (miRNAs) and long ncRNAs (lncRNAs). As yet, lncRNAs are known to serve key biological roles via various mechanisms, such as splicing regulation, chromatin rearrangement, translation regulation, cell-cycle control, genetic imprinting and mRNA decay. Besides, miRNAs govern gene expression by modulation of mRNAs and lncRNAs degradation, suggestive of needing more research in this field. Generally, driving gynecological cancers pathways by miRNAs and lncRNAs lead to the current improvement in cancer-related technologies. Exosomes are extracellular microvesicles which can carry cargo molecules among cells. In recent years, more studies have been focused on exosomal non-coding RNAs (exo-ncRNAs) and exosomal microRNAs (exo-miRs) because of being natural carriers of lnc RNAs and microRNAs via programmed process. In this review we summarized recent reports concerning the function of exosomal microRNAs and exosomal long non-coding RNAs in gynecological cancers.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exosome; Gynecologic cancers; Long non-coding RNAs; MicroRNAs

Year:  2021        PMID: 33581845     DOI: 10.1016/j.ygyno.2021.02.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

1.  NEAT1 in bone marrow mesenchymal stem cell-derived extracellular vesicles promotes melanoma by inducing M2 macrophage polarization.

Authors:  Yemei Yang; Shengfang Ma; Zi Ye; Yushi Zheng; Zhenjiong Zheng; Xiongshan Liu; Xianyi Zhou
Journal:  Cancer Gene Ther       Date:  2022-02-03       Impact factor: 5.854

2.  Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.

Authors:  Aiping Dong; Bin Xu; Zhanzhao Wang; Xia Miao
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

Review 3.  The emerging roles of exosomal long non-coding RNAs in bladder cancer.

Authors:  Qiang Liu
Journal:  J Cell Mol Med       Date:  2022-01-03       Impact factor: 5.310

4.  LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.

Authors:  Duo Li; Rui Wang; Na Wu; Yongqiang Yu
Journal:  Aging (Albany NY)       Date:  2022-02-18       Impact factor: 5.682

5.  Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer.

Authors:  Leilei Liang; Jian Li; Jing Yu; Jing Liu; Lin Xiu; Jia Zeng; Tiantian Wang; Ning Li; Lingying Wu
Journal:  Cancer Cell Int       Date:  2022-03-15       Impact factor: 5.722

6.  Constructe a novel 5 hypoxia genes signature for cervical cancer.

Authors:  Yang Yang; Yaling Li; Ruiqun Qi; Lan Zhang
Journal:  Cancer Cell Int       Date:  2021-07-03       Impact factor: 5.722

7.  Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage.

Authors:  Runjie Sun; Wei Liu; Yangang Zhao; Haoyu Chen; Zhenzhen Wang; Yanyu Zhang; Xiaoqi Sun; Xing Cui
Journal:  Cancer Cell Int       Date:  2021-06-13       Impact factor: 5.722

8.  The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells.

Authors:  Huilin Zhang; Ping He; Qing Zhou; Yan Lu; Bingjian Lu
Journal:  Cancer Cell Int       Date:  2021-07-12       Impact factor: 5.722

9.  Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.

Authors:  Yaogang Wang; Zhigao Chen
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

10.  miR-1270 enhances the proliferation, migration, and invasion of osteosarcoma <em>via</em> targeting cingulin.

Authors:  Yang Liu; Weichun Guo; Shuo Fang; Bin He; Xiaohai Li; Li Fan
Journal:  Eur J Histochem       Date:  2021-12-07       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.